PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
73.31
+2.46 (3.47%)
At close: Aug 7, 2026, 4:00 PM EDT
72.00
-1.31 (-1.79%)
After-hours: Aug 7, 2026, 7:34 PM EDT
PTC Therapeutics Market Cap
PTC Therapeutics has a market cap or net worth of $6.12 billion as of August 7, 2026. Its market cap has increased by 50.31% in one year.
Market Cap
6.12B
Enterprise Value
6.91B
1-Year Change
50.31%
Ranking
Category
Stock Price
$73.31
ChartMarket Cap Chart
Since June 20, 2013, PTC Therapeutics's market cap has increased from $366.20M to $6.12B, an increase of 1,570.81%. That is a compound annual growth rate of 23.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 6.12B | 0.32% |
| Dec 31, 2025 | 6.10B | 75.18% |
| Dec 31, 2024 | 3.48B | 67.39% |
| Dec 29, 2023 | 2.08B | -24.20% |
| Dec 30, 2022 | 2.74B | -2.56% |
| Dec 31, 2021 | 2.82B | -32.38% |
| Dec 31, 2020 | 4.16B | 40.68% |
| Dec 31, 2019 | 2.96B | 70.95% |
| Dec 31, 2018 | 1.73B | 150.23% |
| Dec 29, 2017 | 692.00M | 84.83% |
| Dec 30, 2016 | 374.40M | -66.28% |
| Dec 31, 2015 | 1.11B | -36.17% |
| Dec 31, 2014 | 1.74B | 311.45% |
| Dec 31, 2013 | 422.80M | 15.46% |
| Jun 20, 2013 | 366.20M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Erasca | 6.34B |
| Belite Bio | 6.32B |
| Scholar Rock Holding | 6.31B |
| Xenon Pharmaceuticals | 6.24B |
| Dianthus Therapeutics | 6.15B |
| Definium Therapeutics | 6.12B |
| Ligand Pharmaceuticals | 5.95B |
| Oruka Therapeutics | 5.94B |